Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Jul 29, 2024
$JWN, $SBH, and $COTY Drive Cosmetic Companies to Impressive Weekly Performance Surge

$JWN, $SBH, and $COTY Drive Cosmetic Companies to Impressive Weekly Performance Surge

Robots for this group tickers :
Day Trader, Popular Stocks: Price Action Trading Strategy (TA&FA) 
Swing Trader, Long Only: Valuation & Efficiency Model (FA) - 30-day 

The cosmetic industry has been on a remarkable trajectory, showcasing a substantial 9.48% surge in performance within the past week. This upward movement has brought attention to key players in the sector, primarily including JWN (Nordstrom), SBH (Sally Beauty Holdings), and COTY (Coty Inc.).

Positive Outlook and Technical Indicators

The current scenario presents a positive outlook for these stocks, supported by various technical indicators. The MACD Indicator, a reliable tool for assessing momentum, indicates a positive stance for the mentioned tickers. Moreover, the Stock Fear & Greed Index suggests a favorable sentiment within this industry subset.

Tickeron, a renowned predictive analytics platform, anticipates a further collective increase of over 4.00% within the next month for this group, with a likelihood of 61%. Analyzing the advancing to declining volumes ratio over the last month, which stood at 2.16 to 1, reinforces this positive trend.

Market Cap Overview

Examining market capitalizations within this group reveals an average valuation of around 4.5 billion dollars. The market cap for individual tickers varies, ranging from 1 billion to 10 billion dollars. Notably, COTY holds the highest valuation at 10 billion, while SBH stands as the lowest valued company at 1 billion dollars.

Noteworthy Price Movements

In terms of price fluctuations, the weekly performance across the group witnessed an average growth of 5.4%. However, when considering the monthly statistics, the average growth soared to an impressive 28.73%. Contrarily, the quarterly average price growth demonstrated a marginal decline of -5.52%.

SBH showcased the highest weekly price growth at 9.59%, while COTY faced a decline of -0.67%, reflecting contrasting movements within the same period.

Individual Ticker Insights

  1. Nordstrom (JWN)

    • Noted for its upward trend with the 10-day moving average surpassing the 50-day moving average on November 21, 2023.
    • Historical data indicates an 83% likelihood of continued upward movement following this crossover.
    • Current price movements suggest trading between resistance at $18.59 and support at $15.85.
  2. Sally Beauty Holdings (SBH)

    • The MACD Histogram turned positive on November 14, 2023, indicating a potential uptrend.
    • Historically, in 66% of similar instances, SBH continued to rise after this indicator shift.
    • Present trading range stands between $11.76 support and $10.35 resistance.
  3. Coty Inc. (COTY)

    • Showcased an upward trend by rising above its 50-day moving average on November 14, 2023.
    • With a 77% likelihood, historical data suggests further upward movement in the following month.
    • Present price sits at $11.88, surpassing the $10.25 resistance line found by AI.

Volume Insights

While the average weekly volume growth across the group saw a marginal decrease of -0.38%, the monthly and quarterly averages indicate substantial growth at 52.82% and 41.43%, respectively. Notably, SBH experienced an exceptional daily volume spike, reaching a record-breaking 245% increase against the 65-Day Volume Moving Average on October 3, 2023.

Summary

The cosmetic industry, as depicted by JWN, SBH, and COTY, has witnessed an upward surge in performance, backed by technical indicators and positive market sentiments. Despite individual fluctuations, the overall trajectory appears promising, signaling potential opportunities for investors within this sector.


Contributor

Dem Sem's AvatarDem Sem|Expert

Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
$JWN, $SBH, and $COTY Drive Cosmetic Companies to Impressive Weekly Performance Surge